Fresenius Medical Care wishes you a prosperous and joyful Lunar New Year!. As we welcome the Year of the Snake, we celebrate the strength and wisdom it represents. The snake is a transformational symbol. In this Year of the Snake – united by our values, expertise, and dedication

We are happy to share key dates of our 2025 financial reporting schedule. Mark your calendars and stay tuned for insights into our financial performance, business strategy, and market progress on the following dates. You can also visit our Investor Relations page for more

People with diabetes don’t need to cut out carbs! 🌾 Balanced nutrition, including carbohydrates like whole grains, is key. This #WorldDiabetesDay, FME experts debunk 5 myths. 👇Watch the video to learn the truths! #DiabetesLife #DiabetesAwareness

News📢: Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024. Check out the Q3 earnings information we released today via the press release. We delivered organic revenue growth of +2 % this quarter supported by both segments, Care

Marking National Diabetes Month and #WorldDiabetesDay, we celebrate the strength of those living with diabetes, diabetic kidney disease, and their caregivers. 💙🌎 Be inspired by four of our employees who share their stories. #DiabetesLife #DiabetesAwareness

We are delighted to announce the publication of our 2024 Annual Medical Report (AMR), "Advancing and Personalizing Kidney Disease Care." This year's edition illustrates our unwavering commitment to progressing nephrology and kidney care, and the innovative approaches we undertake

We’re proud to share that Fresenius Medical Care will participate in EDTNA 2024 in Athens! . With around 20 posters and presentations, our diverse team from around the world will showcase innovative research, including the corporate education session, "Is there a place for AI in

We are pleased to announce that Fresenius Medical Care will be attending the ISPD 2024 Congress in Dubai from September 26–29. Join us at booth A111 for an experience that focuses on person-centered care. Click here to register:

High-volume hemodiafiltration (HDF) continues to show superior outcomes compared to traditional hemodialysis (HD) for patients with end-stage kidney disease. The CONVINCE study found that high-volume HDF significantly reduces all-cause mortality, particularly infection-related.

News📢: Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024. Additional #FME25 savings of EUR 57 million achieved in Q2 2024, and on track to reach the upper end of the full year savings target range. We reduced financial debt.

At today’s #AGM2024, 88.39 percent of the share capital was represented. 214 shareholders in person joined the event on site at the Congress Center Messe Frankfurt, Germany. Read the voting results here: #AnnualGeneralMeeting #InvestorRelations.

Our nurses are selfless, compassionate, and resilient, as described by Antonio, a dialysis patient. They transform lives with their exceptional care for people living with chronic kidney disease. 💙 🌟 Explore their inspiring stories here: #INDatFME

We're thrilled to announce our HighVolumeHDF Scientific Dinner event, which will be held in Stockholm on May 24th. Exclusive to ERA Congress attendees. If you are interested, please submit your application here: #ERA24 #DialysisInnovation

News📢: Fresenius Medical Care starts the year 2024 with strong earnings growth. Solid revenue growth of 4% driven by both segments Care Delivery and Care Enablement. Read more in our press release here: #EarningsRelease #QuarterlyReport #Q12024

Kicking off our global #InternationalNursesDay celebrations 🎉 Grateful for our incredible nurses and care teams at Fresenius Medical Care. Your compassion, daily acts of kindness and dedication change lives. Everything you do makes the difference. Thank you! 🩺💙 #INDatFME

At #FreseniusMedicalCare we celebrate the #WorldDayForSafetyandHealthAtWork by reflecting on emerging risks influencing our workforce. Find out more about our Occupational Health and Safety efforts on our Annual Report:

Mark your calendars! 📅 On May 7th, Fresenius Medical Care will release the first quarter earnings. #SaveTheDate to be among the first to read our press release!. #Reporting #EarningsRelease #QuarterlyReport #Q12024 #InvestorRelations

2M worldwide battle kidney failure, often with renal anemia complicating treatment. In the new GMO Dialogues episode, Dr. Luca Neri discusses using AI & computational modeling in anemia management. Watch now to get more insights:

Our CEO Helen Giza sat down with @JudyKShaw from @NYSE for their Floor Talk segment to discuss our transformational journey and the exciting path forward. #TogetherAhead #ProudtobeFME #NYSEFloorTalk.

#News: Fresenius Medical Care delivers on its portfolio management program, announcing the sale of its dialysis clinic networks in Brazil, Colombia, Chile and Ecuador to DaVita Inc., for a total transaction price of USD 300 million. Read the #PressRelease .